Published in J Cancer Res Clin Oncol on May 27, 2008
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol (1982) 8.47
The changing natural history of renal cell carcinoma. J Urol (2001) 4.72
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 3.85
Solid renal tumors: an analysis of pathological features related to tumor size. J Urol (2003) 3.48
Renal cell carcinoma guideline. Eur Urol (2007) 3.42
The results of radical nephrectomy for renal cell carcinoma. J Urol (1969) 3.37
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology (2000) 2.92
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol (2006) 2.17
Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol (2004) 1.39
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol (2006) 1.36
Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology (2005) 1.22
The changing evolution of renal tumours: a single center experience over a two-decade period. Eur Urol (2004) 1.06
Increase of renal cell carcinoma incidence in central Europe. Eur Urol (1998) 1.04
Renal cell carcinoma. Curr Opin Oncol (2006) 0.93
Trends in the operative management of renal tumors over a 14-year period. BJU Int (2006) 0.88
Revisiting the insect mitochondrial molecular clock: the mid-Aegean trench calibration. Mol Biol Evol (2010) 2.98
The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol (2012) 2.37
EAU guidelines on urological trauma. Eur Urol (2005) 1.70
Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin. Int Braz J Urol (2010) 1.48
Enucleoresection for the elective treatment of small renal cell carcinoma: can it be the treatment of choice? Onkologie (2007) 1.45
Spontaneous perforation of the ureter: clinical presentation and endourologic management. J Endourol (2008) 1.29
Testing the species--genetic diversity correlation in the Aegean archipelago: toward a haplotype-based macroecology? Am Nat (2011) 1.15
Giant adrenal myelolipoma, a rare urological issue with increasing incidence: a case report. Cases J (2009) 1.14
Comparative phylogeography of tenebrionid beetles in the Aegean archipelago: the effect of dispersal ability and habitat preference. Mol Ecol (2009) 1.05
Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE. Proteomics (2006) 1.03
Prediction of muscle-invasive bladder cancer using urinary proteomics. Clin Cancer Res (2009) 1.02
Short- and long-term complications of open radical prostatectomy according to the Clavien classification system. BJU Int (2008) 0.98
Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue. Urol Res (2004) 0.95
Symptomatic benign prostate hyperplasia: impact on partners' quality of life. Eur Urol (2002) 0.94
Synchronous chromophobe and papillary renal cell carcinoma. First report and review of the pathogenesis theories. Pathol Int (2009) 0.93
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer. Urology (2011) 0.91
Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population. Asian J Androl (2015) 0.90
TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH: a tool for standard preoperative work-up? Int Urol Nephrol (2009) 0.86
Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate. Urology (2006) 0.86
Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder. Anticancer Res (2006) 0.86
Superior mesenteric artery dissection after extracorporeal shockwave lithotripsy. Case Rep Vasc Med (2012) 0.86
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model. BMC Cancer (2010) 0.84
Prognostic significance of metallothionein expression in renal cell carcinoma. World J Surg Oncol (2005) 0.84
Clinical significance of routine urinary bacterial culture after transurethral surgery: results of a prospective multicenter study. Urology (2012) 0.83
Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics (2009) 0.83
Renal cell carcinoma with bilateral synchronous adrenal gland metastases: a case report. Cases J (2009) 0.83
Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer. Anticancer Res (2005) 0.83
Patient awareness of smoking as a risk factor for bladder cancer. Int Urol Nephrol (2009) 0.82
Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urol Res (2002) 0.82
Effect of a hypercholesterolemic diet on serum lipid profile, plasma sex steroid levels, and prostate structure in rats. Urology (2010) 0.82
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival. Anticancer Res (2011) 0.82
Multiple metastases of prostatic adenocarcinoma to the urethra after radical prostatectomy. Urol Int (2007) 0.81
Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol (2006) 0.80
Quantitative study of mast cells in experimentally induced benign prostatic hyperplasia. Urol Int (2010) 0.79
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group. Anticancer Drugs (2016) 0.79
Ureterointestinal strictures following Bricker ileal conduit: management via a percutaneous approach. Int Urol Nephrol (2008) 0.79
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study. Urology (2004) 0.79
Vascular endothelial growth factor protein expression in a renal ablation rabbit model under prolonged warm and cold ischemia. Am J Nephrol (2007) 0.79
Terazosin modifies the content of glycosaminoglycans and the activity of matrix metalloproteinase 2 in the rat ventral prostate. Eur Urol (2006) 0.79
Effects of prolonged warm and cold ischemia in a solitary kidney animal model after partial nephrectomy: an ultrastructural investigation. Ultrastruct Pathol (2011) 0.79
In vivo effect of the lipido-sterolic extract of Serenoa repens (Permixon) on mast cell accumulation and glandular epithelium trophism in the rat prostate. World J Urol (2002) 0.78
The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans. Nitric Oxide (2005) 0.78
A solitary fibrous tumor of the kidney in a 26-year-old man. Can J Urol (2007) 0.78
Primary adenocarcinoma of the seminal vesicles. A review of the literature. Arch Ital Urol Androl (2016) 0.77
Local anesthesia during transrectal ultrasonography-guided prostate biopsy: does it have any effect on sexual function? Int Urol Nephrol (2006) 0.77
Terazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate. Clin Invest Med (2009) 0.77
Hydronephrosis promotes expression of hypoxia-inducible factor 1 alpha. Urol Int (2009) 0.77
In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice. Arch Ital Urol Androl (2016) 0.76
In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG). Anticancer Res (2007) 0.76
Ephrins and pain. Expert Opin Ther Targets (2013) 0.76
MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomas. Anticancer Res (2006) 0.76
DNA ploidy and immunomarking of bladder urothelial tumors before and after intravesical bacillus Calmette-Guérin treatment. Anal Quant Cytol Histol (2005) 0.76
Laparoscopic pyeloplasty for ureteropelvic junction obstruction of the lower moiety in a completely duplicated collecting system: a case report. J Med Case Rep (2008) 0.75
Primary enteric-type mucinous adenocarcinoma of the urethra in a patient with ulcerative colitis. Int Surg (2014) 0.75
Radical cystectomy over the age of 75 is safe and increases survival. BMC Geriatr (2012) 0.75
Inverted papilloma of the ureter: study of a rare case with emphasis on clinicopathologic implications. Can Urol Assoc J (2012) 0.75
Bilateral dilation of the urinary tract due to iliopsoas pyomyositis: a case report. J Med Case Rep (2011) 0.75
Contemporary diagnosis of bladder cancer. Expert Opin Med Diagn (2008) 0.75
Castrati singers: surgery for religion and art. Ital J Anat Embryol (2014) 0.75
Beta-adrenergic receptor blockade and prostate peptide growth factor expression in the rat. Immunopharmacol Immunotoxicol (2010) 0.75
Changes in end products of nitric oxide in urine and induction of nitric oxide synthase expression in urinary bladder during intravesical instillations of IFN-alpha2b. J Interferon Cytokine Res (2004) 0.75
Prognostic factors identifying biochemical recurrence in patients with positive margins after radical prostatectomy. Int Urol Nephrol (2010) 0.75
Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study. Pharmacogenomics (2012) 0.75
The impact of body mass on management of patients with renal colic. Int Urol Nephrol (2003) 0.75
Idiopathic spontaneous perforation of the upper urinary tract. A presentation of 4 cases. Arch Ital Urol Androl (2014) 0.75
Change of practice patterns in urology with the introduction of the Da Vinci surgical system: the Greek NHS experience in debt crisis era. Arch Ital Urol Androl (2015) 0.75
Clear cell carcinoma of the lower urinary tract in a male patient. Presentation and update on histogenesis and management. Pathol Int (2009) 0.75
Influence of HIV virus in the hospital stay and the occurrence of postoperative complications classified according to the Clavien-Dindo classification and in comparison with the Charlson Comorbidity Index in patients subjected to urologic and general surgery operations. Our preliminary results. Arch Ital Urol Androl (2017) 0.75
Comparison of the self-reported training level between Mexican and Western Europe residents in urology: results of an international survey. Med Teach (2009) 0.75